MedTrace Logo

A Study in Healthy Volunteers Comparing Two Different Liquid Formulations of Solifenacin With Each Other and With the Tablet Formulation

NCT01406158 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2011-08-24

No results posted yet for this study

Summary

A study in healthy volunteers comparing two different liquid formulations of solifenacin with each other and with the tablet formulation.

Conditions

  • Pharmacokinetics of Solifenacin Succinate
  • Healthy Volunteers

Interventions

DRUG

Solifenacin Succinate Formulation A

oral suspension

DRUG

Solifenacin Succinate Formulation B

oral suspension

DRUG

Solifenacin Succinate

oral tablet

Sponsors & Collaborators

  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • Medical Director · Astellas Pharma Global Development

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01406158 on ClinicalTrials.gov